Price
228.25
+0.61%52W Range
Market Cap
₹2,649.66 Cr
Traded: ₹5.38 Cr (0.20%) 0.0x
Free Float: ₹944.87 Cr (0.57% of FF traded)
Volume · 60D trend
2.36 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +30.0% | +24.0% | -- | +6.0% | Decelerating |
| ROE | -- | +14.0% | +11.0% | -- | -- | Decelerating |
| Return | -- | -- | -- | +142.0% | -- | -- |
| Profit | -- | +35.0% | +56.0% | -- | +52.0% | Stable |
Quarterly Results
Sep 2024
Jun 2024
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 121 | 110 | 105 | 106 | 110 | 152 | 85 | 68 | 73 |
| Expenses | 99 | 94 | 93 | 90 | 96 | 133 | 71 | 66 | 61 |
| Operating Profit | 22 | 16 | 12 | 16 | 14 | 19 | 14 | 2 | 12 |
| OPM % | 18.0% | 15.0% | 11.0% | 15.0% | 13.0% | 12.0% | 17.0% | 2.9% | 17.0% |
| Other Income | 3 | 1 | 2 | 0 | 0 | 2 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 1 |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 25 | 17 | 13 | 15 | 14 | 18 | 12 | 1 | 11 |
| Tax % | 25.0% | 34.0% | 16.0% | 25.0% | 25.0% | 27.0% | 20.0% | -56.0% | 26.0% |
| Net Profit | 19 | 11 | 11 | 11 | 10 | 13 | 10 | 1 | 8 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 1.6 | 0.9 | 1.0 | 1.0 | 0.9 | 1.1 | 1.1 | 0.1 | 0.9 |
| Sales Growth (YoY) | 10.0% | -27.6% | 23.5% | 55.9% | 50.7% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 10.0% | 4.8% | -0.9% | -3.6% | -27.6% | 78.8% | 25.0% | -6.8% | -- |
| OP Growth (YoY) | 57.1% | -15.8% | -14.3% | 700.0% | 16.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | 37.5% | 33.3% | -25.0% | 14.3% | -26.3% | 35.7% | 600.0% | -83.3% | -- |
| Profit Growth (YoY) | -- | -17.6% | 13.8% | 1243.5% | 23.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | 79.8% | -17.5% | -11.9% | 988.9% | -5.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 70.2% | -2.1% | -2.0% | 10.1% | -21.9% | 4.6% | 1111.1% | -90.4% | -- |
| OP Margin | 18.2% | 14.6% | 11.4% | 15.1% | 12.7% | 12.5% | 16.5% | 2.9% | 16.4% |
| Net Margin | 15.7% | 10.0% | 10.5% | 10.4% | 9.1% | 8.6% | 11.8% | 1.5% | 11.0% |
| Material Cost % | 76.0% | 79.0% | 82.0% | 80.0% | 80.0% | 79.0% | 73.0% | 73.0% | 77.0% |
| Employee Cost % | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 4.0% | 3.0% | 1.0% | 1.0% |
| P/S | 5.99 | 6.50 | -- | -- | -- | -- | -- | -- | -- |
| P/E | 50.95 | 64.01 | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.89 | 4.11 | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Transcript of the Investor Conference with regard to the business and financial performance of the Company for the quarter ended 30th June, 2026.
As per the attachment
Audio Recording of the Earnings Conference Call held on 17th August, 2026 to discuss the Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2026.
Investor Presentation for the Financial Results for the Quarter ended on 30th June, 2026.
Press release titled " Stallion India Fluorochemicals Reports Strong Q1 FY27 Performance; PAT Surges 79% YoY to Rs. 18.59 Crore"
Monitoring Agency Report for the quarter ended on 30th June, 2026 with respect to the utilisation of proceeds of the IPO.
As per attachment
Intimation regarding Q1 FY 2026-27 Earnings Call.
Outcome of Board Meeting held on 12th August, 2026
Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of ....
Intimation of Schedule of Analyst/Investor Meeting pursuant to be held on Tuesday, 21st July, 2026.
As per the attachment
As per the attachment
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Corporate Advisory Ltd & Neomile Growth ....
Result of Postal Ballot
Transcript of the Investor Conference for the business and financial performance of the Company for the Quarter & Financial Year ended on 31st March, 2026.
As per the attachment.
As per the attachment.
Annual Secretarial Compliance Report for the Financial Year ended on 31st March, 2026.
As per the attachment.
As per the attachment.
As per the attachment
Outcome of Board Meeting held on 13th May, 2026
As per the attachment.
Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve As per the attachment.
Newspaper Advertisement - Postal Ballot Notice
Postal Ballot Notice
Clarification regarding Movement in Price.
The Exchange has sought clarification from Stallion India Fluorochemicals Ltd on April 23, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....
As per the attachment
As per the attachment.
Outcome of the Board Meeting held on 20th April, 2026
Intimation of schedule of Analyst/Investor Meet/Call pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
As per the attachment
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st March, 2026.
As per the attachment.
As per the attachment.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Corporate Advisory Ltd & Neomile Growth ....
As per the attachment.
Approval of allotment of shares w.r.t. Rights Issue of the Company.
Revised Outcome
As per attachment.
Submission of copy of Newspaper Advertisement for opening of Right Issue of the Company.
Submission of copy of Newspaper Advertisement for opening of Right Issue of the Company.
Monitoring Agency Report for the Quarter ended on 31sst December, 2025.
As per the attachment.
Outcome of Board Meeting held today i.e. Thursday, 12th February, 2026
Stallion India Fluorochemicals Limited''s R-32 Plant in Bhilwara, Rajasthan to benefit from subsidy for the eligible fixed capital investment from comprehensive incentives under RIPS 2024.
Stallion India Fluorochemicals Limited signs MoU with Government of Rajasthan to Set up HFO Manufacturing Plant.
Transcript of the Investor Conference held on Tuesday, 03rd February, 2026 with regard to the business and financial performance of the Company for the Quarter & Nine Months ended on 31st ....
Annual Reports
12025
Concalls
5Feb 2026
28 Feb 2026Oct 2025
31 Oct 2025Aug 2025
31 Aug 2025May 2025
31 May 2025